|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 02-16-2005
GAITHERSBURG, Md. (Reuters) - U.S. scientific advisers began hearing evidence on Wednesday about the benefits and risks of pain killers taken by millions of Americans as regulators weigh moves following Merck & Co. Inc.'s recall of its arthritis pill Vioxx.
LONDON (Reuters) - The world's leading drugmakers are racing to be first to market with a new kind of pill that can block the AIDS virus before it enters human cells, experts said on Wednesday.
WASHINGTON (Reuters) - Babies' DNA can be damaged even before they are born if their mothers breathe polluted air, according to a study published on Tuesday.
WASHINGTON (Reuters) - Doctors who led three studies showing prescription painkillers called COX-2 inhibitors raise the risk of heart attacks and stroke said on Tuesday the whole class of drugs was in danger of being pulled from the market.
ROCKVILLE, Md. (Reuters) - Two topical creams used to treat the skin condition eczema need a stronger warning on their labels about the possible risk of cancer, U.S. medical experts said on Tuesday.
CHICAGO (Reuters) - Sudden jumps of HIV levels in patients taking drugs for the AIDS-causing infection are harmless blips and do not mean the treatment against the virus is losing its punch, a report said on Tuesday.
BERLIN (Reuters) - A donor whose organs were used in transplants by six German hospitals had probably contracted rabies before dying, one of the hospitals said on Wednesday.
CHICAGO (Reuters) - A urine test that detects proteins given off by malignant growths can identify bladder cancer faster and perhaps reduce the use of more invasive procedures, researchers said on Tuesday.
CHICAGO (Reuters) - Doctors were able to eliminate the need for insulin injections in diabetic women for a year or more by simplifying the technique of transplanting insulin-producing cells, a small study said on Tuesday.
ROCKVILLE, Md. (Reuters) - The U.S. Food and Drug Administration said on Tuesday it was creating a new drug safety board to improve the monitoring of medicines already in the marketplace, a response to charges the agency has failed to protect the public from dangerous side effects.
|
|
